[CD30 (Ki-1+) anaplastic large cell lymphomas]

Ann Dermatol Venereol. 1989;116(11):881-3.
[Article in French]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antigens, Differentiation / immunology
  • Antigens, Neoplasm / immunology
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biomarkers, Tumor
  • Bleomycin / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Female
  • Humans
  • Immunohistochemistry
  • Ki-1 Antigen
  • Lymphoma / drug therapy
  • Lymphoma / immunology
  • Lymphoma / pathology*
  • Male
  • Middle Aged
  • Phenotype
  • Prognosis
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / immunology
  • Skin Neoplasms / pathology*
  • Vincristine / administration & dosage

Substances

  • Antigens, Differentiation
  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • Ki-1 Antigen
  • Bleomycin
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide

Supplementary concepts

  • ACVB protocol